-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Chemotherapy-Free Frontline Therapy for CLL: Is It Worth It?

Program: Education Program
Session: A Map for the Changing Landscape of CLL
Hematology Disease Topics & Pathways:
Leukemia, therapy sequence, Diseases, CLL, drug-drug interaction, Therapies, Combinations, Adverse Events, B-Cell Lymphoma, Lymphoid Malignancies, Clinically relevant
Saturday, December 5, 2020, 7:25 AM-7:30 AM

Jacqueline C. Barrientos, MD

Department of Medicine, Hofstra North Shore - LIJ School of Medicine, Great Neck, NY

Disclosures: Barrientos: Abbvie: Consultancy; AstraZeneca: Consultancy; Pharmacyclics/Abbvie: Consultancy; Kite/Gilead: Consultancy; Velosbio: Research Funding; Oncternal: Research Funding.

OffLabel Disclosure:

See more of: A Map for the Changing Landscape of CLL
See more of: Education Program
<< Previous Presentation | Next Presentation >>